In a model of double human brain tumors in mice mimicking brain metastasis, the NIA could be modified with specific antibodies for tumor targeting, such as trastuzumab for HER2+ breast cancer targeting or cetuximab for EGFR+ U87MG GBM targeting. Here, EGFR is linked to glioblastoma.